M
PFE icon

Mirova’s Pfizer PFE Stock Holding History

Mirova’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-68,408
Closed -$1.66M – 123
2025
Q2 		$1.66M Sell
68,408
-3,807
-5% -$88.8K 0.23% 74
2025
Q1 		$1.83M Hold
72,215
– – 0.33% 62
2024
Q4 		$1.92M Sell
72,215
-8,488
-11% -$230K 0.33% 62
2024
Q3 		$2.34M Hold
80,703
– – 0.4% 56
2024
Q2 		$2.26M Buy
80,703
+76,736
+1,934% +$2.11M 0.41% 54
2024
Q1 		$110K Hold
3,967
– – 0.02% 113
2023
Q4 		$114K Sell
3,967
-243
-6% -$7.35K 0.02% 98
2023
Q3 		$140K Sell
4,210
-11,093
-72% -$392K 0.03% 96
2023
Q2 		$561K Sell
15,303
-18,888
-55% -$735K 0.1% 88
2023
Q1 		$1.39M Sell
34,191
-235
-0.7% -$10.2K 0.2% 81
2022
Q4 		$1.76M Buy
34,426
+3,229
+10% +$155K 0.28% 75
2022
Q3 		$1.36M Sell
31,197
-5,197
-14% -$253K 0.23% 74
2022
Q2 		$1.91M Buy
36,394
+3,893
+12% +$198K 0.27% 64
2022
Q1 		$1.68M Sell
32,501
-548
-2% -$28.4K 0.23% 61
2021
Q4 		$1.95M Sell
33,049
-653
-2% -$32.4K 0.23% 60
2021
Q3 		$1.45M Buy
33,702
+3,088
+10% +$137K 0.19% 65
2021
Q2 		$1.2M Buy
30,614
+1,839
+6% +$71.5K 0.14% 70
2021
Q1 		$1.04M Buy
28,775
+3,953
+16% +$140K 0.12% 73
2020
Q4 		$913K Buy
24,822
+19,163
+339% +$703K 0.12% 68
2020
Q3 		$197K Sell
5,659
-1,470
-21% -$51.5K 0.03% 69
2020
Q2 		$221K Sell
7,129
-139
-2% -$4.72K 0.05% 58
2020
Q1 		$225K Sell
7,268
-2,854
-28% -$97.2K 0.09% 51
2019
Q4 		$376K Buy
10,122
+4,028
+66% +$143K 0.13% 53
2019
Q3 		$208K Buy
6,094
+551
+10% +$20K 0.03% 65
2019
Q2 		$228K Hold
5,543
– – 0.02% 54
2019
Q1 		$223K Buy
5,543
+1,656
+43% +$66.3K 0.12% 40
2018
Q4 		$161K Buy
+3,887
New +$161K 0.07% 42

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mirova's PFE Position: Q3 2025 in Review

Mirova sold out of Pfizer (PFE) in Q3 2025, closing a stake of 68,408 shares — an estimated $1.66M sold.

Mirova first reported a position in PFE in Q4 2018 and held it in 27 quarters. The position peaked at $2.34M in Q3 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Mirova reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Mirova sold 68,408 Pfizer shares in Q3 2025, an estimated $1.66M.
  • Mirova first reported a position in Pfizer in Q4 2018 and held it in 27 quarters.
  • Mirova's Pfizer position peaked at $2.34M in Q3 2024.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Mirova's 13F filing for Q3 2025, filed 29 Dec 2025.